The Associate Director will lead the biomarker strategy, managing assay operations and analyzing biomarker data across clinical studies at Apogee Therapeutics.

Lead and manage the Oversight CRAs team for clinical trial oversight, ensuring study deliverables meet quality and regulatory standards, while contributing to operational readiness and risk-based monitoring strategies.

Lead late-stage clinical development readiness for Phase 3 studies and BLA submissions, ensuring cross-functional collaboration and effective project management.